MedTrace Logo

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

NCT02796079 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 240

Last updated 2017-04-06

No results posted yet for this study

Summary

Stem cell therapy has been a new and effective therapy in recent years for diabetic foot.This study intends to establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.

Conditions

  • Peripheral Vascular Disease
  • Ischemia
  • Diabetic Foot

Interventions

BIOLOGICAL

mesenchymal stem cells

stem cell acquisition, processing and reinfection, to evaluate the efficacy by using autologous bone marrow stem cell

BIOLOGICAL

saline

saline injections

Sponsors & Collaborators

  • Nanfang Hospital, Southern Medical University

    collaborator OTHER

  • Academy Military Medical Science, China

    collaborator INDUSTRY

  • The Fifth Affiliated Hospital of Southern Medical University

    collaborator OTHER

  • Southern Medical University, China

    collaborator OTHER

  • Jie Shen

    lead OTHER_GOV

Principal Investigators

  • Jie Shen · The Third Affiliated Hospital of Southern Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2018-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02796079 on ClinicalTrials.gov